Translational Immunobiology MSc
Research into improving therapy for patients has been developing since the 1990s. This unique programme builds on the recent successes in the clinical applications of immunotherapy for a range of immune-mediated diseases – for example, the use of anti-TNF therapies in rheumatoid arthritis patients – and drawing on faculty-wide expertise, focuses on the processes involved in translating immunobiology research, using the eye as a model.
Mode of study
- Full-time 1 year
- UK/EU Full-time: £9,550
- Overseas Full-time: £23,000
- All applicants: 1 August 2014
More details in Application section.
What will I learn?
The processes involved in translating immunological discoveries into predictive, diagnostic and/or therapeutic applications are described in depth, using examples of successful translational studies to illustrate key aspects: the clinical question; study design and limitations. Students will also attend scientific lectures in relevant subject areas (immunology, molecular cell biology, pharmacology), gaining hands-on experience in an original research project.
Why should I study this degree at UCL?
UCL is the largest centre for biomedical research in the UK – with immunobiology, immunity and infection all major specialities across the university – and offers unique opportunities to study translational immunobiology.
The UCL Institute of Ophthalmology is an international leader in translational research and clinical and industrial collaborations are in place. UCL academics who advise on aspects of research methodology involved in successful translational projects – the design of studies, applications for Ethics approval, funding applications, peer-review publications, data presentation and writing skills – will also provide case studies, presentations and seminars.
The eye is an excellent model for monitoring disease activity, responses to therapy, and clinical scoring, and is an ideal organ through which to study pathological and anatomical changes as the responses in the eye can also be used to inform on other sites in the body. The eye is also a very accessible site for delivering new therapies.
Students undertake modules to the value of 180 credits. The programme consists of five core modules (75 credits), three optional modules (45 credits), and a dissertation/report (60 credits).
Students will carry out an independent research project supervised by internationally recognised researchers, resulting in a dissertation of 10,000–12,000 words and an oral presentation/viva voce.
Teaching and Learning
The programme is delivered through a combination of lectures, seminars and student group presentations. Assessment is through a mixture of unseen examinations, coursework (essays, bioinformatic tasks, practicals), a major dissertation, and oral presentations.
Further details available on subject website:
Further information about funding and scholarships can be found on the Scholarships and funding website.
A minimum of an upper second-class UK Bachelor’s degree in medicine, biomedical science, or another relevant discipline, or an overseas qualification of an equivalent standard.
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of a good level of English proficiency.
Select your country for equivalent alternative requirements
English language proficiency level: Good
How to apply
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
The deadline for applications is 1 August 2014.
Who can apply?
The programme is best suited to science graduates or clinicians looking to further their career in translational research, either in academia or a pharmaceutical setting. Alternatively, the programme will be highly useful for scientists or clinicians looking to move into related areas such as clinical trials, research regulation and management.
What are we looking for?
When we assess your application we would like to learn:
- why you want to study Translational Immunobiology at graduate level
- why you want to study Translational Immunobiology at UCL
- what particularly attracts you to this programme
- how your personal, academic and professional background meets the demands of this challenging programme
- where you would like to go professionally with your degree
The first cohort of students on the Translational Immunobiology MSc are due to graduate in 2015, therefore no information on graduate destinations is currently available.
This programme is of particular interest to those science graduates considering alternative career directions in addition to mainstream research. Due to the translational content, this programme offers key knowledge and skills with wider applications outside of academia for those interested in pursuing clinical trial design, governance, clinical trial management, and grants administration within relevant governmental bodies, the pharmaceutical and medical industry.
Dr Virginia Calder
T: +44 (0)20 7608 6968
Register your interest
Keep up to date with news from UCL and receive personalised email alerts. Register your interest
Make an application
"In London, and at UCL in particular, I am surrounded by excellent colleagues who have helped me to shape my research in numerous ways. At least half of the techniques we use today in the laboratory were unknown to me until I joined UCL and started collaborating with colleagues."
Professor Matteo Carandini
Professor of Visual Neuroscience
"Participating in some observership clinics with my supervisor was extremely helpful for me, and writing the dissertation with all the new things I learned from this experience. Ophthalmology is one of the fastest evolving medical specialties, and dealing with vision was always my dream."
Degree: Clinical Ophthalmology MSc